Replies to post #548 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

If ENTA opts in for profit sharing on the ABT-493 + ABT-530 program, accounting for the JV would presumably be audited by a third party. If anything, the opportunity for skimming by ABBV would be greater under the royalty (no opt-in) scenario.